James C. Hawley
Director of Finance/CFO at CIMA Labs, Inc.
Profile
Jim Hawley joined MGI PHARMA in January 2005 as Senior Vice President and was appointed Chief Financial Officer in March 2005.
Prior to joining MGI PHARMA, Mr. Hawley served as Vice President, Chief Financial Officer, and Corporate Secretary at CIMA LABS INC.
Prior to his officer roles with CIMA LABS, he was a Principal with Manchester Companies, Inc., a private investment banking and management advisory firm, and joined Orthomet Inc., an innovative developer and marketer of implantable medical devices, as Chief Financial Officer, later becoming Executive Vice President.
In addition to his positions at CIMA LABS and Orthomet, Mr. Hawley served as Chief Executive Officer and Director of Harmony Brook, Inc. and Interim Chief Executive Officer and Director of CARA Collision and Glass.
Mr. Hawley also spent 12 years in various financial roles at 3M Company, including Group Controller of the Pharmaceutical and Dental Products Group.
Mr. Hawley has served on the board of directors at Navarre Biomedical Ltd.
and Kelly Russell Studios, Inc. Mr. Hawley received his BS with distinction from the University of Minnesota before working in and receiving his certificate in public accounting.
James C. Hawley active positions
Companies | Position | Start |
---|---|---|
CIMA Labs, Inc.
CIMA Labs, Inc. Pharmaceuticals: OtherHealth Technology CIMA Labs, Inc. develops and manufactures prescription and over-the-counter pharmaceutical products using fast-dissolve drug delivery technologies. It develops orally disintegrating technology based OraSolv and DuraSolv tablets. It also develops tranmucosal tablets that can be administered sublingually. The company is headquartered in Brooklyn Park, MN. | Director of Finance/CFO | 2009-12-13 |
Former positions of James C. Hawley
Companies | Position | End |
---|---|---|
Medwave, Inc.
Medwave, Inc. Medical SpecialtiesHealth Technology Medwave, Inc. engages in the developing, manufacturing and selling of non-invasive, blood pressure measurement and monitoring systems related technologies. It develops sensor-based non-invasive blood pressure solutions. The company was founded in 1984 and is headquartered in Arden Hills, MN. | Director/Board Member | 2007-12-03 |
MGI PHARMA, Inc.
MGI PHARMA, Inc. Pharmaceuticals: MajorHealth Technology MGI PHARMA, INC. develops, manufactures & markets pharmaceutical and medical products for therapeutic markets. The company's products include Aloxi injection, Dacogen, Gliadel water, Hexalen capsules, and Salagen Tablets. It has alliances with Helsinn Healthcare SA, Kissei Pharmaceutical Co. Ltd., Dainippon Pharmaceutical Co. Ltd., Pfizer, Inc. and Novartis Pharma AG. The company was founded in 1979 and is headquartered in Bloomington, MN. | Director of Finance/CFO | 2006-04-24 |
Training of James C. Hawley
University of Minnesota | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 3 |
---|---|
MGI PHARMA, Inc.
MGI PHARMA, Inc. Pharmaceuticals: MajorHealth Technology MGI PHARMA, INC. develops, manufactures & markets pharmaceutical and medical products for therapeutic markets. The company's products include Aloxi injection, Dacogen, Gliadel water, Hexalen capsules, and Salagen Tablets. It has alliances with Helsinn Healthcare SA, Kissei Pharmaceutical Co. Ltd., Dainippon Pharmaceutical Co. Ltd., Pfizer, Inc. and Novartis Pharma AG. The company was founded in 1979 and is headquartered in Bloomington, MN. | Health Technology |
Medwave, Inc.
Medwave, Inc. Medical SpecialtiesHealth Technology Medwave, Inc. engages in the developing, manufacturing and selling of non-invasive, blood pressure measurement and monitoring systems related technologies. It develops sensor-based non-invasive blood pressure solutions. The company was founded in 1984 and is headquartered in Arden Hills, MN. | Health Technology |
CIMA Labs, Inc.
CIMA Labs, Inc. Pharmaceuticals: OtherHealth Technology CIMA Labs, Inc. develops and manufactures prescription and over-the-counter pharmaceutical products using fast-dissolve drug delivery technologies. It develops orally disintegrating technology based OraSolv and DuraSolv tablets. It also develops tranmucosal tablets that can be administered sublingually. The company is headquartered in Brooklyn Park, MN. | Health Technology |
- Stock Market
- Insiders
- James C. Hawley